Modern Chinese Medicine Group Co., Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG6181B1068
HKD
0.50
-0.03 (-5.66%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'20
Dec'19
Dec'18
Net Sales
105.11
50.87
53.03
Other Operating Income
0.00
0.00
0.00
Total Operating income
105.11
50.87
53.03
Raw Material Cost
60.07
30.19
29.41
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
Employee Cost
4.28
2.88
3.03
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.07
0.00
0.00
Selling and Distribution Expenses
13.18
2.21
2.18
Other Expenses
-0.03
-0.02
-0.30
Total Expenditure (Excl Depreciation)
77.34
35.09
31.59
Operating Profit (PBDIT) excl Other Income
27.799999999999997
15.8
21.400000000000002
Other Income
0.23
0.06
0.06
Operating Profit (PBDIT)
28.56
15.77
21.17
Interest
0.07
0.00
0.00
Exceptional Items
-7.32
-13.06
0.00
Gross Profit (PBDT)
45.03
20.68
23.62
Depreciation
0.58
0.44
0.46
Profit Before Tax
20.59
9.58
20.71
Tax
7.95
3.68
5.21
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
12.64
5.90
15.50
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
12.64
5.90
15.50
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
12.64
5.90
15.50
Equity Capital
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
Reserves
159.86
77.02
141.20
Earnings per share (EPS)
0.02
0.01
0.03
Diluted Earnings per share
0.02
0.01
0.03
Operating Profit Margin (Excl OI)
26.42%
30.02%
38.94%
Gross Profit Margin
20.14%
19.7%
39.93%
PAT Margin
12.03%
11.6%
29.23%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2020 is 106.48% vs -3.96% in Dec 2019

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2020 is 113.56% vs -61.94% in Dec 2019

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2020 is 80.25% vs -25.59% in Dec 2019

stock-summary

Interest

YoY Growth in quarter ended Dec 2020 is 0.00% vs 0.00% in Dec 2019

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2020 has fallen from Dec 2019

Compare Quarterly Results Of Modern Chinese Medicine Group Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
105.11
0
105.11
Other Operating Income
0.00
0.00
0.00
Total Operating income
105.11
0
105.11
Raw Material Cost
60.07
0
60.07
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
4.28
0
4.28
Power Cost
0
0
0.00
Manufacturing Expenses
0.07
0
0.07
Selling and Distribution Expenses
13.18
0
13.18
Other Expenses
-0.03
0.00
-0.03
Total Expenditure (Excl Depreciation)
77.34
0
77.34
Operating Profit (PBDIT) excl Other Income
27.76
0.00
27.76
Other Income
0.23
0
0.23
Operating Profit (PBDIT)
28.56
0
28.56
Interest
0.07
0
0.07
Exceptional Items
-7.32
0
-7.32
Gross Profit (PBDT)
45.03
0
45.03
Depreciation
0.58
0
0.58
Profit Before Tax
20.59
0
20.59
Tax
7.95
0
7.95
Provisions and contingencies
0.00
0
0.00
Profit After Tax
12.64
0
12.64
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
12.64
0
12.64
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
12.64
0
12.64
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
159.86
0
159.86
Earnings per share (EPS)
0.02
0
0.02
Diluted Earnings per share
0.02
0
0.02
Operating Profit Margin (Excl OI)
26.42%
0%
0.00
26.42%
Gross Profit Margin
20.14%
0%
0.00
20.14%
PAT Margin
12.03%
0%
0.00
12.03%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 10.51 Million
in Dec 2020

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2020 is 106.48%

stock-summary

YoY Growth in quarter ended Dec 2020 is 106.48% vs -3.96% in Dec 2019

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.26 Million
in Dec 2020

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2020 is 113.56%

stock-summary

YoY Growth in quarter ended Dec 2020 is 113.56% vs -61.94% in Dec 2019

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.83 Million
in Dec 2020

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2020 is 80.25%

stock-summary

YoY Growth in quarter ended Dec 2020 is 80.25% vs -25.59% in Dec 2019

Quarterly - Interest
Interest 0.01 Million
in Dec 2020

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2020 is 0.00%

stock-summary

YoY Growth in quarter ended Dec 2020 is 0.00% vs 0.00% in Dec 2019

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.42%
in Dec 2020

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2020 has fallen from Dec 2019

stock-summary

YoY Growth in quarter ended Dec 2020 has fallen from Dec 2019